Medicare Enrolled
Dr. George Munoz, M.D.
Rheumatology · Miami, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Munoz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Munoz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Munoz
Dr. George Munoz is a rheumatology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Munoz performed 71,255 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Munoz received a total of $186,460 from 33 pharmaceutical and/or device companies across 605 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Munoz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 32% volume in FL
$186,460 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗71,255
Medicare services
Top 32% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
46,400 | $4 | $11 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
9,000 | $11 | $27 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,925 | $34 | $84 |
| Denosumab injection (Prolia/Xgeva) | 5,100 | $18 | $43 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
385 | $57 | $189 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
198 | $106 | $345 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
180 | $13 | $85 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $99 | $270 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
125 | $6 | $17 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
98 | $0 | $5 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
83 | $149 | $364 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
79 | $4 | $60 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 65 | $14 | $28 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
63 | $31 | $77 |
| Wrist X-ray, minimum 3 views An imaging test using X-rays to capture at least three different angles of the wrist bones and joints. |
62 | $33 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $137 | $415 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
47 | $34 | $290 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
45 | $49 | $270 |
| Knee X-ray, 4 or more views An imaging test using X-rays to create multiple pictures of the knee joint from different angles. |
41 | $38 | $123 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
37 | $1 | $3 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $11 | $64 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
26 | $23 | $80 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
22 | $31 | $88 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
22 | $29 | $73 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
19 | $40 | $104 |
| New patient office visit, complex (60-74 min) | 13 | $190 | $521 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
25.5% high complexity
73.7% medium
0.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$186,460
Total received (2018-2024)
Avg $26,637/year across 7 years
Top 6% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
605
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,248
2023
$31,966
2022
$42,254
2021
$11,274
2020
$8,435
2019
$26,006
2018
$50,277
Payments by company (2024)
UCB, Inc.
$13,840
Janssen Biotech, Inc.
$875
ABBVIE INC.
$482
GENZYME CORPORATION
$275
Amgen Inc.
$245
Alexion Pharmaceuticals, Inc.
$139
GlaxoSmithKline, LLC.
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
DePuy Synthes Sales Inc.
$68
Alvogen Inc
$53
Mallinckrodt Hospital Products Inc.
$30
E.R. Squibb & Sons, L.L.C.
$27
PFIZER INC.
$24
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 93.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$172,506
Mallinckrodt LLC
$3,939
Janssen Biotech, Inc.
$2,546
ABBVIE INC.
$1,066
Horizon Therapeutics plc
$1,061
Amgen Inc.
$1,049
Lilly USA, LLC
$605
GlaxoSmithKline, LLC.
$487
GENZYME CORPORATION
$396
E.R. Squibb & Sons, L.L.C.
$331
PFIZER INC.
$315
Alexion Pharmaceuticals, Inc.
$287
AstraZeneca Pharmaceuticals LP
$243
Radius Health, Inc.
$237
Mallinckrodt Hospital Products Inc.
$189
Alvogen Inc
$156
DePuy Synthes Sales Inc.
$125
Aurinia Pharma U.S., Inc.
$117
AbbVie Inc.
$111
Novartis Pharmaceuticals Corporation
$109
Allergan Inc.
$94
AbbVie, Inc.
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Integra LifeSciences Corporation
$54
Horizon Pharma plc
$50
MEDAC PHARMA, INC.
$46
Flexion Therapeutics, Inc.
$34
Fresenius Kabi USA, LLC
$34
Mallinckrodt Enterprises LLC
$34
MEDEXUS PHARMA, INC.
$32
Ferring Pharmaceuticals Inc.
$21
Organon LLC
$18
Cardinal Health 108 LLC
$13
Top 3 companies account for 96.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BENLYSTA · Bimzelx · CODMAN CERTAS · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · NATRELLE · OMNIGRAFT · ORENCIA · ORTHOVISC · PENNSAID · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
93
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Munoz is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Munoz experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Munoz performed 46,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Munoz receive payments from pharmaceutical companies?
Yes. Dr. Munoz received a total of $186,460 from 33 companies across 605 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Munoz's costs compare to other rheumatologists in Miami?
Dr. Munoz's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Munoz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Miami
Browse rheumatologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Mallinckrodt LLC Payments to Doctors
See all physicians who received payments from Mallinckrodt LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology